Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 7/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | MPI | P34949 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 3/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | AGXT | P21549 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1815294 | 0.83 | MIF (0.71) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL2141861 | 0.82 | MIF (0.77) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL4701206 | 0.81 | MIF (0.68) | MIFTRPA1IDO1TAAR1 | |
| SCHEMBL5372 | 0.80 | MIF (0.67) | MIFALDH1A1CYP3A4MPIIDO1 | |
| SCHEMBL23342229 | 0.78 | MIF (0.65) | MIFALDH1A1CYP3A4MPIIDO1 | |
| 3-Methoxybenxyl Isothiocyanate SCHEMBL1551644 | 0.78 | MIF (0.64) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL10566112 | 0.78 | MIF (0.64) | MIFTRPA1ALDH1A1TAAR1ALOX15 | |
| SCHEMBL4779914 | 0.77 | MIF (0.68) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL1706732 | 0.77 | MIF (0.63) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL9610849 | 0.77 | MIF (0.63) | MIFTRPA1ALDH1A1CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 431 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3969163-B1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | claimed |
| EP-4452941-A1 | ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-10-30 | — | — | EP | claimed |
| WO-2023117119-A1 | ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2023-06-29 | — | — | WO | claimed |
| EP-3687311-A1 | AMIDES FOR GENERATING A TRIGEMINAL EFFECT | Symrise AG (DE) | 2020-08-05 | — | — | EP | claimed |
| EP-3142499-B1 | HOMOVANILLIC ACID ESTERS, IN PARTICULAR FOR ACHIEVING AN IMPRESSION OF HEAT AND/OR SPICINESS | SYMRISE AG (DE) | 2019-10-30 | — | — | EP | claimed |
| WO-2019063069-A1 | AMIDES FOR GENERATING A TRIGEMINAL EFFECT | SYMRISE AG (DE) | 2019-04-04 | — | — | WO | claimed |
| EP-2742983-B1 | Method for isolating fragrance and flavour compounds | SYMRISE AG (DE) | 2017-08-23 | — | — | EP | claimed |
| EP-3142499-A1 | HOMOVANILLIC ESTER, MORE PARTICULARLY FOR ACHIEVING AN IMPRESSION OF HEAT AND/OR SPICINESS | Symrise AG (DE) | 2017-03-22 | — | — | EP | claimed |
| US-20160250175-A1 | COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE | JC (WUXI) COMPANY, INC. (CN) | 2016-09-01 | — | — | US | claimed |
| US-20160198747-A1 | 1H-PYRROLE-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS | IMAX DISCOVERY GMBH (DE) | 2016-07-14 | — | — | US | claimed |
| WO-2015014607-A1 | IMIDAZO[1,2-A]PYRIDINE-YLMETHYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS | IMAX DISCOVERY GMBH (DE) | 2015-02-05 | — | — | WO | claimed |
| WO-2015014609-A1 | 1H-PYRROLE-2,4-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS | IMAX DISCOVERY GMBH (DE) | 2015-02-05 | — | — | WO | claimed |
| EP-2832234-A1 | Imidazo[1,2-a]pyridine-ylmethyl-derivatives and their use as flavoring agents | IMAX Discovery GmbH (DE) | 2015-02-04 | — | — | EP | claimed |
| EP-2832233-A1 | 1H-pyrrole-2,4-dicarbonyl-derivatives and their use as flavoring agents | IMAX Discovery GmbH (DE) | 2015-02-04 | — | — | EP | claimed |
| CN-104117064-A | Combined application of isothiocyanate compound and hormone medicine | WUXI JC PHARMACAUTICAL TECHNOLOGY INC | 2014-10-29 | — | — | CN | claimed |
| EP-2742983-A1 | Method for isolating fragrance and flavour compounds | Symrise AG (DE) | 2014-06-18 | — | — | EP | claimed |
| WO-2013135511-A1 | N-(2,4-DIMETHYLPENTAN-3-YL)-METHYLBENZAMIDES AND THEIR USE AS FLAVORING AGENTS | IMAX DISCOVERY GMBH (DE) | 2013-09-19 | — | — | WO | claimed |
| EP-2008530-B1 | Aroma composition for reducing or suppressing unwanted bitter and astringent impressions | SYMRISE AG (DE) | 2011-01-19 | — | — | EP | claimed |
| EP-2008530-A1 | Aroma composition for reducing or suppressing unwanted bitter and astringent impressions | Symrise GmbH & Co. KG (DE) | 2008-12-31 | — | — | EP | claimed |
| US-20080317923-A1 | AROMA COMPOSITION FOR REDUCING OR SUPPRESSING AN UNDESIRED BITTER, ASTRINGENT IMPRESSION | SYMRISE GMBH & CO. KG (DE) | 2008-12-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160250175-A1 | COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE | CHUK, KIT, MKI67 | MIF 986/4885TRPA1 2138/4885ALDH1A1 2081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.